AfroCentric posts mixed annual results with a 74.9% profit drop due to impairments, but higher headline earnings signal a recovery in SA’s pharmaceutical sector.
AfroCentric reports mixed results amid strategic investments
Original Article by Jacob Webster | Business Day | 3 September 2024
AfroCentric posts mixed annual results with a 74.9% profit drop due to impairments, but higher headline earnings signal a recovery in SA's pharmaceutical sector.
More Posts
Thembisile Xulu Named New Health Director-General
Dr Thembisile Xulu is the new health Director-General, inheriting a strained department, healthcare-worker shortages and NHI litigation.
Read more...
Gauteng Nurse Shortage Deepens, Threatening NHI Rollout
Gauteng is losing 100 nurses a month and needs R5.7bn to fill a 16,000-post gap. This shortage now flagged as a key risk to the NHI rollout.
Read more...
Medical Schemes Should Be Allowed to Offer Low-Cost Benefit Options
Regulation, not demand, blocks affordable cover: medical schemes should be allowed to offer low-cost benefit options (LCBOs) now.
Read more...